New data from the MK-8591A-051 and MK-8591A-052 trials, both investigating the efficacy and safety of 100-mg doravirine and 0.25-mg islatravir as a once-daily 2-drug regimen for virologically ...

February is the shortest month, but there was still plenty of time for a rush of pharma and biotech hires, including a number ...

MilliporeSigma Chief Technology Officer Brings Extensive Science, Technology, and Innovation Leadership Experience Wiley (NYSE: WLY), one of the world's largest publishers and a trusted leader in ...

Wiley (NYSE: WLY), one of the world's largest publishers and a trusted leader in research and learning, today announced the appointment of Karen N. Madden, Ph.D., to its Board of Directors. Madden is ...

Innovative Digital Platform Empowers HIV Patients with Personalized Support to Address HIV-Associated Wasting and Fatigue BOSTON, MA / ACCESS Newswire / March 5, 2025 / Medisafe, the leading global di ...

We’re a month into the year, and there’s so much excitement to come in the Boston-area food and drink world. Below, we’re tracking some of the forthcoming restaurants, bars, bakeries ...

Shah and colleagues take advantage of the presence of maternal and somatic ribosomes in zebrafish and confirm their differential expression during development. The authors convincingly show that ...

RUPERT -- Merck Forest & Farmland Center (MFFC) announces the appointment of Tom O’Handley as its new Senior Director of Development. His leadership comes at a pivotal time as MFFC embarks on its 75th ...

We recently published a list of 10 Best Retirement Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other best ...

In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other best retirement stocks to buy according to hedge funds. After much suspense, the US Federal ...

Merck is bracing for the years of sales growth from oncology superstar Keytruda to take a sharp turn in 2028—and for more reasons than one. Along with a key U.S. patent expiring at the end of ...